Home/Pipeline/Low Carbon pMDI Transition Program

Low Carbon pMDI Transition Program

Respiratory (enabling technology)

CommercializationActive

Key Facts

Indication
Respiratory (enabling technology)
Phase
Commercialization
Status
Active
Company

About Bespak

Bespak is a leading specialist CDMO in the inhalation and nasal drug delivery space, with a legacy dating back to 1969. The company is at the forefront of the industry's sustainability transition, actively developing and scaling manufacturing for low Global Warming Potential (GWP) propellants for pMDIs. Its core business involves providing end-to-end services and proprietary device platforms, such as the widely adopted BK357 valve, to pharmaceutical partners globally, helping them bring combination products to market.

View full company profile

Therapeutic Areas